These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 38284707)

  • 1. Zebrafish Experimental Animal Models for AD: A Comprehensive Review.
    Sande R; Godad A; Doshi G
    Curr Rev Clin Exp Pharmacol; 2024; 19(4):295-311. PubMed ID: 38284707
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Zebrafish as a Promising Tool for Modeling Neurotoxin-Induced Alzheimer's Disease.
    Thawkar BS; Kaur G
    Neurotox Res; 2021 Jun; 39(3):949-965. PubMed ID: 33687726
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Alzheimer's disease.
    De-Paula VJ; Radanovic M; Diniz BS; Forlenza OV
    Subcell Biochem; 2012; 65():329-52. PubMed ID: 23225010
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Development of a Novel and Robust Pharmacological Model of Okadaic Acid-induced Alzheimer's Disease in Zebrafish.
    Nada SE; Williams FE; Shah ZA
    CNS Neurol Disord Drug Targets; 2016; 15(1):86-94. PubMed ID: 26295819
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Molecular and functional signatures in a novel Alzheimer's disease mouse model assessed by quantitative proteomics.
    Kim DK; Park J; Han D; Yang J; Kim A; Woo J; Kim Y; Mook-Jung I
    Mol Neurodegener; 2018 Jan; 13(1):2. PubMed ID: 29338754
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Behavioural, genomics and proteomic approach to examine Alzheimer's disease in zebrafish.
    Siddiqui A; Abidin SAZ; Shah ZA; Othman I; Kumari Y
    Comp Biochem Physiol C Toxicol Pharmacol; 2023 Sep; 271():109636. PubMed ID: 37100105
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Generation of Alzheimer's Disease Transgenic Zebrafish Expressing Human APP Mutation Under Control of Zebrafish appb Promotor.
    Pu YZ; Liang L; Fu AL; Liu Y; Sun L; Li Q; Wu D; Sun MJ; Zhang YG; Zhao BQ
    Curr Alzheimer Res; 2017; 14(6):668-679. PubMed ID: 27978793
    [TBL] [Abstract][Full Text] [Related]  

  • 8. APP transgenic modeling of Alzheimer's disease: mechanisms of neurodegeneration and aberrant neurogenesis.
    Crews L; Rockenstein E; Masliah E
    Brain Struct Funct; 2010 Mar; 214(2-3):111-26. PubMed ID: 20091183
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Brilliance of the Zebrafish Model: Perception on Behavior and Alzheimer's Disease.
    Shenoy A; Banerjee M; Upadhya A; Bagwe-Parab S; Kaur G
    Front Behav Neurosci; 2022; 16():861155. PubMed ID: 35769627
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Alzheimer's disease pathogenesis and therapeutic interventions.
    Parihar MS; Hemnani T
    J Clin Neurosci; 2004 Jun; 11(5):456-67. PubMed ID: 15177383
    [TBL] [Abstract][Full Text] [Related]  

  • 11. An Animal Model to Test Reversal of Cognitive Decline Associated with Beta-Amyloid Pathologies.
    Deba F; Peterson S; Hamouda AK
    Methods Mol Biol; 2019; 2011():393-412. PubMed ID: 31273712
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Synaptic changes in Alzheimer's disease and its models.
    Pozueta J; Lefort R; Shelanski ML
    Neuroscience; 2013 Oct; 251():51-65. PubMed ID: 22687952
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Spontaneous and induced nontransgenic animal models of AD: modeling AD using combinatorial approach.
    Kaushal A; Wani WY; Anand R; Gill KD
    Am J Alzheimers Dis Other Demen; 2013 Jun; 28(4):318-26. PubMed ID: 23687185
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Insights on the Use of Transgenic Mice Models in Alzheimer's Disease Research.
    Pádua MS; Guil-Guerrero JL; Prates JAM; Lopes PA
    Int J Mol Sci; 2024 Feb; 25(5):. PubMed ID: 38474051
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A new insight on Al-maltolate-treated aged rabbit as Alzheimer's animal model.
    Bharathi ; Shamasundar NM; Sathyanarayana Rao TS; Dhanunjaya Naidu M; Ravid R; Rao KS
    Brain Res Rev; 2006 Sep; 52(2):275-92. PubMed ID: 16782202
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Human neural stem cells improve cognition and promote synaptic growth in two complementary transgenic models of Alzheimer's disease and neuronal loss.
    Ager RR; Davis JL; Agazaryan A; Benavente F; Poon WW; LaFerla FM; Blurton-Jones M
    Hippocampus; 2015 Jul; 25(7):813-26. PubMed ID: 25530343
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The pathology of APP transgenic mice: a model of Alzheimer's disease or simply overexpression of APP?
    Howlett DR; Richardson JC
    Histol Histopathol; 2009 Jan; 24(1):83-100. PubMed ID: 19012248
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A{beta} accelerates the spatiotemporal progression of tau pathology and augments tau amyloidosis in an Alzheimer mouse model.
    Hurtado DE; Molina-Porcel L; Iba M; Aboagye AK; Paul SM; Trojanowski JQ; Lee VM
    Am J Pathol; 2010 Oct; 177(4):1977-88. PubMed ID: 20802182
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Alzheimer disease: cellular and molecular aspects].
    Octave JN
    Bull Mem Acad R Med Belg; 2005; 160(10-12):445-9; discussion 450-1. PubMed ID: 16768248
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Transgenic models of Alzheimer's disease: learning from animals.
    Spires TL; Hyman BT
    NeuroRx; 2005 Jul; 2(3):423-37. PubMed ID: 16389306
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.